Genetic testing and biotechnology company 23andMe is facing numerous challenges, including more than 30 lawsuits.
Breaking News
Home genetics startup 23andMe has secured a $1.4 million two-year grant from the National Institutes of Health (NIH) to build survey tools and expand its gene database.
23andMe Chief Executive Officer Anne Wojcicki defended her company's genetic testing product and stands by the data on the accuracy of their results after the public warning letter issued by the US Food and Drug Administration.
Russian millionaire and entrepreneur Yuri Milner recently led a Series B funding round for genetics upstart GenapSys for the commercialization of the company's genome-sequencing platform.
The personal genomic and biotechnology corporation in the US would target people's DNA by selling their genetic information for US$99.
Subscribe to VCpost newsletter
Most Popular
- 940,000 Taxpayers May Receive Extra $932 Tax Refunds From IRS; Here's Why!
- Where's My Child Tax Credit 2024: When to Receive My Money After April 15 Tax Filing Deadline?
- SSDI Payment April 2024: Who Will Receive Social Security Benefits Today?
- In the Era of Shrinkflation, Cinemark Sued for Allegedly Swindling Customers by Shortchanging Them on Beverages
- SSI Payment for May 2024: Supplemental Security Income Recipients to See Double Amount in Payout
- Philippines Wants US, Japan to Fund Freight Railway Project After It Drops Funding Talks With China
- Convicted Fraudster Accused of Killing Wealthy Heiress Wife in Swimming Pool to Cash in on Over $4 Million Fortune
- Trump's $175 Million Fraud Bond is not Properly Backed, According to New York AG
